BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32213163)

  • 61. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
    Bash LD; Black W; Turzhitsky V; Urman RD
    Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: a prospective, randomised, double-blind trial in high-risk older patients.
    Ledowski T; Szabó-Maák Z; Loh PS; Turlach BA; Yang HS; de Boer HD; Asztalos L; Shariffuddin II; Chan L; Fülesdi B
    Br J Anaesth; 2021 Aug; 127(2):316-323. PubMed ID: 34127252
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
    Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
    BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
    Gaszynski T; Szewczyk T; Gaszynski W
    Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study.
    Azimaraghi O; Ahrens E; Wongtangman K; Witt AS; Rupp S; Suleiman A; Tartler TM; Wachtendorf LJ; Fassbender P; Choice C; Houle TT; Eikermann M; Schaefer MS
    Br J Anaesth; 2023 Mar; 130(3):296-304. PubMed ID: 36535827
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects on Postoperative Gastrointestinal Motility After Neuromuscular Blockade Reversal With Sugammadex Versus Neostigmine/Glycopyrrolate in Colorectal Surgery Patients.
    Hunt ME; Yates JR; Vega H; Heidel RE; Buehler JM
    Ann Pharmacother; 2020 Dec; 54(12):1165-1174. PubMed ID: 32468846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
    Jiang Y; Bash LD; Saager L
    Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: A randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period.
    Moon TS; Reznik S; Pak T; Jan K; Pruszynski J; Kim A; Smith KM; Lu R; Chen J; Gasanova I; Fox PE; Ogunnaike B
    J Clin Anesth; 2020 Apr; 64():109804. PubMed ID: 32353805
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial.
    Baysal A; Sagıroglu G; Dogukan M; Ozkaynak I
    J Perianesth Nurs; 2022 Jun; 37(3):326-332. PubMed ID: 35153119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.
    Hurford WE; Welge JA; Eckman MH
    J Clin Anesth; 2020 Dec; 67():110027. PubMed ID: 32980763
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study.
    Min BH; Oh TK; Song IA; Jeon YT
    BMC Anesthesiol; 2020 Jul; 20(1):178. PubMed ID: 32693776
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is sugammadex superior to neostigmine in reversing rocuronium-induced neuromuscular blockade?
    Bartlett E; Urman RD; Urits I; Kaye AD; Viswanath O
    J Clin Anesth; 2022 Aug; 79():110288. PubMed ID: 33875335
    [No Abstract]   [Full Text] [Related]  

  • 78. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
    Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
    Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
    Schaller SJ; Fink H; Ulm K; Blobner M
    Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.